ImmuPharma Revenue

ImmuPharma had revenue of -69.96K GBP in the twelve months ending June 30, 2024, down -200.00% year-over-year.

Revenue (ttm)

-69.96K

Revenue Growth

-200.00%

P/S Ratio

n/a

Revenue / Employee

-13.99K

Employees

Market Cap

17.49M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	118.35K	-8.32K	-6.57%
Dec 31, 2020	126.67K	48.74K	62.55%
Dec 31, 2019	77.93K	-3.36K	-4.13%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AstraZeneca	43.19B
GSK plc	31.38B
Haleon	11.24B
Smith & Nephew	4.46B
Hikma Pharmaceuticals	2.39B
ConvaTec Group	1.74B
HUTCHMED (China)	483.31M
Oxford Nanopore Technologies	167.75M

Revenue Rankings

ImmuPharma News

6 weeks ago - AIM Market Roundup: Immupharma, Poolbeg, Xeros - The Armchair Trader
5 months ago - Three Quick Facts: Norman Broadbent, Computacenter, Immupharma - The Armchair Trader

More News